mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
mRNA |
etoposide |
GDSC1000 |
pan-cancer |
AAC |
0.0023 |
0.9 |
mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
0.0024 |
0.9 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.0022 |
0.9 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0023 |
1 |
mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
-0.0021 |
1 |
mRNA |
CID-5951923 |
CTRPv2 |
pan-cancer |
AAC |
0.0021 |
1 |
mRNA |
BRD-K63431240 |
CTRPv2 |
pan-cancer |
AAC |
0.0018 |
1 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0018 |
1 |
mRNA |
KU-55933 |
GDSC1000 |
pan-cancer |
AAC |
0.0015 |
1 |